advanced search

Welcome: Guest

log in

Digestive System Hemorrhoids

Publication Date March 2008
Publisher Life Science Analytics
Product Type Report
Pages 67
ISBN Number not applicable
Product Code LSA02343
Price

£800.00
approximately: $1,169 | €877

PDFBuy Now
PRINT £850 ($1,242 | €932)Buy Now
Order above formats by FAXOrder by FAX

Summary

Life Science Analytics', Women's Health Contraception contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.

Scope of the report:

Each Life Science Analytics' Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.

In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.

Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.

Key benefits

  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
  • Keep track of your competitors and partners by better understanding their product pipeline.
  • Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
  • Maintain a critical competitive advantage.

Content

  • Recent Highlights and Changes
  • Upcoming Patent Expires by Therapy Area
    • Contraception Pipeline Overview
      • % of Projects (by Phase of Development)
      • No. of Projects by Phase of Development
    • Company Overview - Pipeline Projects
      • Company Overview - Pipeline Projects
      • Top Companies in late stage Contraception Projects
      • Amphastar Pharmaceuticals, Inc.
      • Agile Therapeutics, Inc.
      • Bayer Schering Pharma AG
      • Barr Pharmaceuticals Inc
      • Cellegy Pharmaceuticals Inc
      • BioSante Pharmaceuticals Inc
      • Merck KGaA
      • HRA Pharma
      • Polydex Pharmaceuticals Ltd
      • Pantarhei Bioscience
      • Schering-Plough Corp
      • ProStrakan Group plc
      • Top Companies in early stage Contraception Projects
      • Acrux Limited
      • Addex Pharmaceuticals SA
      • Antares Pharma Inc
      • HRA Pharma
      • Ligand Pharmaceuticals Inc
      • Novavax Inc
      • Starpharma Holdings Ltd
    • Pipeline Revenue
      • Pipeline Revenue
    • Full Pipeline View
      • Pre Clinical Pipeline View
      • Phase I Pipeline View
      • Phase II Pipeline View
      • Phase III Pipeline View
      • Pending Approval Pipeline View
      • on the Market Pipeline View
      • Discovery/Development Pipeline View